Bendanillo, Jeanito M.

HRN: 18-05-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/24/2024
03/02/2024
IV
500mg
Q8
T/C Intestinal Amoebiasis
Waiting Final Action 
02/25/2024
METRONIDAZOLE 500MG (TAB)
02/25/2024
03/03/2024
PO
500
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: